Adnexal mass
during
Caesarean section
Prof. Aboubakr
Elnashar
Benha university Hospital, Egypt
1/19/2019 ABOUBAKR ELNASHAR
Gynecological
1. Uterine
1. Hysterectomy
2. Myomectomy
3. IUD insertion
2. Extra uterine:
1. Ovarian cystectomy
2. Oophrectomy
3. Tubal ligation
4. Salpingectomy
Non gynecological
1. Intraperitoneal
appendectomy
2. Extraperitoneal
1. Abdominoplasty
2. Excision of ugly scar
II. From another incision
1. Hernioplasty
2. Cholecystectomy
OPERATINS DURING CS
I. From same incision
1/19/2019 ABOUBAKR ELNASHAR
1.Planned
1. Hernioplasty
2. Cholecystectomy
3. Abdominoplasty
2.Not planned
1.Ovarian cystectomy
2.Hysterectomy
1/19/2019 ABOUBAKR ELNASHAR
CONTENTS
1.INCIDENCE
2.TIME OF DIAGNOSIS
3.TYPES
4.MANAGEMENT
 CONCLUSION
1/19/2019 ABOUBAKR ELNASHAR
1. INCIDENCE
 During pregnancy
1–4% of all pregnancies
1.methods of detection
2.differences in the definition of clinically
significant masses
3.adequate health care.
 Steadily increasing
 widespread use of ultrasound, other imaging
techniques
1/19/2019 ABOUBAKR ELNASHAR
 During CS
 0.49%
 increased by the increased rate of CS
(Ulker et al, 2010)
 1.64%
(Yu et al, 2018)
1/19/2019 ABOUBAKR ELNASHAR
2. TIME OF DIAGNOSIS
 During pregnancy:
 Only 29.78%
 although 99.00% received a antenatal
examination.
 more than half of the masses were diagnosed
incidentally during CS.
(Baser et al, 2013)
1/19/2019 ABOUBAKR ELNASHAR
 Why?
1. Most adnexal masses
 Asymptomatic
 small (≤5 cm)
2. Pregnant patients refused
1. pelvic examination
2. TVS for the fear of abortion
3. Some adnexal masses might
 emerge after pregnancy
 gravid uterus may obscure the correct
visualization and detection.
 it is important to promote the use of USG and
improve the USG technique during preconception and
prenatal visits.
1/19/2019 ABOUBAKR ELNASHAR
3. TYPES
Ulker et al, 2010
1/19/2019 ABOUBAKR ELNASHAR
Follicular cyst1/19/2019 ABOUBAKR ELNASHAR
Histological types
and sizes of
adnexal
masses
surgically
removed during
cesarean section
Cristian et al, 2012
1/19/2019 ABOUBAKR ELNASHAR
1/19/2019 ABOUBAKR ELNASHAR
Cengiz et al, 2012
1/19/2019 ABOUBAKR ELNASHAR
Ovarian serous cystadenoma
1/19/2019 ABOUBAKR ELNASHAR
Baser
et al,
2013
1/19/2019 ABOUBAKR ELNASHAR
Huge paraovarian cyst
1/19/2019 ABOUBAKR ELNASHAR
Yu et al, 2018
1300 CS
1/19/2019 ABOUBAKR ELNASHAR
Theca lutein cysts
1/19/2019 ABOUBAKR ELNASHAR
1/19/2019 ABOUBAKR ELNASHAR
1/19/2019 ABOUBAKR ELNASHAR
4. MANAGEMENT
 During pregnancy
 Risk of obsrvation
 torsion
 rupture
 bleeding,
 obstruction, or
 malignancy.
 Risk of Surgery
 intraoperative and perioperative risks
 fetal loss
 preterm contractions
 an increased risk of embolic events
1/19/2019 ABOUBAKR ELNASHAR
< 5 cm
 Observation
 cystic benign-appearing
{Early in pregnancy, this is likely a corpus
luteum cyst, which typically resolves by the
early second trimester}.
 Excision
 sonographic characteristics suggest cancer-
 thick septa
 nodules,
 papillary excrescences, or
 solid components
(William,2018)
1/19/2019 ABOUBAKR ELNASHAR
 Unilocular
 Thin-walled
 Anechoic
Follicular cyst1/19/2019 ABOUBAKR ELNASHAR
Simple ultrasound rules: 2012
5 ultrasonic features to predict a malignant tumour
(M features):
Irregular solid tumour (M1),
Ascites (M2),
At least four papillary structures (M3),
Irregular multilocular solid tumour with a largest
diameter of at least 100 mm (M4)
Very high colour content on colour Doppler
examination (M5).
ABOUBAKR ELNASHAR1/19/2019
5 ultrasonic features to predict a benign tumour (B
features):
Unilocular cyst (B1),
Presence of solid components for which the largest
solid component is <7 mm in largest diameter (B2)
Acoustic shadows (B3)
Smooth multilocular tumour (B4)
No detectable blood flow on Doppler examination
(B5).
ABOUBAKR ELNASHAR1/19/2019
1/19/2019 ABOUBAKR ELNASHAR
1/19/2019 ABOUBAKR ELNASHAR
5 - 10 cm
 color Doppler and possibly MRI
 Observation
 simple cystic appearance
(Schmeler, 2005; Zan etta, 2003) .
 Excision
 display malignant qualities
 symptomatic
 cysts grow
10 cm:
Excision
{substantial risk of malignancy, torsion, or labor
obstruction}
1/19/2019 ABOUBAKR ELNASHAR
 Resection
 When
 at 14 to 20 w
 {most masses that will regress will have done
so by this time}.
 If the corpus luteum is removed before 10W:
17-OH-progesterone, 250 mg IM/W tell 10W
gestation.
 Laparoscopic removal is ideal
(Naqvi, 20 1 5 ; Sisodia, 2015 )
 If cancer is strongly suspected,
 consultation with a gynecologic oncologist.
(ACOG, 2017)
1/19/2019 ABOUBAKR ELNASHAR
During CS:
If diagnosed during ante natal
 Plan of management before delivery.
 Consent for removal
 Paracentesis
for huge masses to minimize their volume and avoid
complications
 Endometrioma or mature cystic teratoma
 may be resected
 postpartum or
 during CS for obstetrical indications.
1/19/2019 ABOUBAKR ELNASHAR
 Removal of all masses during CS, especially if the
larger than 5 cm,
 Why?
1. to prevent
 subsequent complications:
 torsion or rupture
 future requirement for surgery
2. removal during CS was not associated with any
complications.
 Why all masses
considerable proportion of neoplastic lesions were
smaller than 5 cm
1/19/2019 ABOUBAKR ELNASHAR
If incidentally discovered
 Incidence: 1 in 200
 Exteriorizing the uterus during CS:
 less intraoperative complications
 less hemorrhage
 better inspection of pelvic organs: incidental
adnexal mass discovery not such a rare event.
1/19/2019 ABOUBAKR ELNASHAR
 Medico-legal issues on the informed consenting
process
 additional procedures during CS should not be
carried out without further discussion with the
woman
 This includes procedures which
 may be appropriate but
 not essential at the time,
 such as ovarian cystectomy or
oophorectomy
 Additional non-emergency procedures during a cesarean section should not be
carried out without the consent of the woman.
[RCOG, 2016]. .
1/19/2019 ABOUBAKR ELNASHAR
Under general anesthesia
 If an ovarian cyst suggestive of malignancy:
• Seek an on-the-table review by an oncology
specialist.
• Take peritoneal washings for cytology.
• Consider biopsies of cyst wall or visible
peritoneal lesions.
 when she is conscious
 Inform the patient of the findings
 seek her permission to send any specimens for
laboratory investigations.
 Plan definitive management in consultation with
a gynecologic oncologist.
1/19/2019 ABOUBAKR ELNASHAR
Under regional anesthesia
• Inform and seek consent for further management.
• If the cyst appears benign:
 consider performing a cystectomy, but without
spillage of cyst contents.
• If the cyst suggestive of malignancy:
 take peritoneal washings
 consider performing an oophorectomy with or
without additional surgery.
 The procedure should be performed by an
oncology specialist.
 Once histology is available, interval staging
laparotomy can be planned as appropriate.
1/19/2019 ABOUBAKR ELNASHAR
 Incidental adnexal masses should be surgically
removed,
 avoiding later surgery
 establishing malignancy status of the mass.
 no complication or increase of morbidity and
mortality
 safe surgical act.
1/19/2019 ABOUBAKR ELNASHAR
 Type of operation
 depending on the
1. manifestation of the masses.
2. exclude malignancies
 with a biopsy (or wedge resection) and then
freeze the section in order to avoid
unnecessary surgical excision.
 frozen section
 offers a great help in making an
intraoperative decision
 unfortunately a 24 hs frozen section
examination not available.
 referral of the patient to an oncological
center after CS will not influence
negatively the patient’s chances.1/19/2019 ABOUBAKR ELNASHAR
 Cystectomy
 is the recommended procedure, if no malignancy
 signs
 Ovarectomy and ovarectomy with salpingectomy:
complex cases.
 ovarian masses should be removed intact when
possible, especially in suspicious cases.
1/19/2019 ABOUBAKR ELNASHAR
CONCLUSION
 Preconception care and routine prenatal care,
including USG examination, may optimize the
detection and management of an adnexal mass.
 Removal of incidental or known adnexal masses at
cesarean section, especially if they are larger than
5cm.
1/19/2019 ABOUBAKR ELNASHAR
You can get this lecture and 400
lectures from:
1.My scientific page on Face book: Aboubakr
Elnashar Lectures.
https://www.facebook.com/groups/22774488
4091351/
2.Slide share web site
3. elnashar53@hotmail.com
4.My clinic: Althwara st, Mansura, Egypt
1/19/2019 ABOUBAKR ELNASHAR

Adnexal mass during Caesarean section

  • 1.
    Adnexal mass during Caesarean section Prof.Aboubakr Elnashar Benha university Hospital, Egypt 1/19/2019 ABOUBAKR ELNASHAR
  • 2.
    Gynecological 1. Uterine 1. Hysterectomy 2.Myomectomy 3. IUD insertion 2. Extra uterine: 1. Ovarian cystectomy 2. Oophrectomy 3. Tubal ligation 4. Salpingectomy Non gynecological 1. Intraperitoneal appendectomy 2. Extraperitoneal 1. Abdominoplasty 2. Excision of ugly scar II. From another incision 1. Hernioplasty 2. Cholecystectomy OPERATINS DURING CS I. From same incision 1/19/2019 ABOUBAKR ELNASHAR
  • 3.
    1.Planned 1. Hernioplasty 2. Cholecystectomy 3.Abdominoplasty 2.Not planned 1.Ovarian cystectomy 2.Hysterectomy 1/19/2019 ABOUBAKR ELNASHAR
  • 4.
  • 5.
    1. INCIDENCE  Duringpregnancy 1–4% of all pregnancies 1.methods of detection 2.differences in the definition of clinically significant masses 3.adequate health care.  Steadily increasing  widespread use of ultrasound, other imaging techniques 1/19/2019 ABOUBAKR ELNASHAR
  • 6.
     During CS 0.49%  increased by the increased rate of CS (Ulker et al, 2010)  1.64% (Yu et al, 2018) 1/19/2019 ABOUBAKR ELNASHAR
  • 7.
    2. TIME OFDIAGNOSIS  During pregnancy:  Only 29.78%  although 99.00% received a antenatal examination.  more than half of the masses were diagnosed incidentally during CS. (Baser et al, 2013) 1/19/2019 ABOUBAKR ELNASHAR
  • 8.
     Why? 1. Mostadnexal masses  Asymptomatic  small (≤5 cm) 2. Pregnant patients refused 1. pelvic examination 2. TVS for the fear of abortion 3. Some adnexal masses might  emerge after pregnancy  gravid uterus may obscure the correct visualization and detection.  it is important to promote the use of USG and improve the USG technique during preconception and prenatal visits. 1/19/2019 ABOUBAKR ELNASHAR
  • 9.
    3. TYPES Ulker etal, 2010 1/19/2019 ABOUBAKR ELNASHAR
  • 10.
  • 11.
    Histological types and sizesof adnexal masses surgically removed during cesarean section Cristian et al, 2012 1/19/2019 ABOUBAKR ELNASHAR
  • 12.
  • 13.
    Cengiz et al,2012 1/19/2019 ABOUBAKR ELNASHAR
  • 14.
  • 15.
  • 16.
  • 17.
    Yu et al,2018 1300 CS 1/19/2019 ABOUBAKR ELNASHAR
  • 18.
  • 19.
  • 20.
  • 21.
    4. MANAGEMENT  Duringpregnancy  Risk of obsrvation  torsion  rupture  bleeding,  obstruction, or  malignancy.  Risk of Surgery  intraoperative and perioperative risks  fetal loss  preterm contractions  an increased risk of embolic events 1/19/2019 ABOUBAKR ELNASHAR
  • 22.
    < 5 cm Observation  cystic benign-appearing {Early in pregnancy, this is likely a corpus luteum cyst, which typically resolves by the early second trimester}.  Excision  sonographic characteristics suggest cancer-  thick septa  nodules,  papillary excrescences, or  solid components (William,2018) 1/19/2019 ABOUBAKR ELNASHAR
  • 23.
     Unilocular  Thin-walled Anechoic Follicular cyst1/19/2019 ABOUBAKR ELNASHAR
  • 24.
    Simple ultrasound rules:2012 5 ultrasonic features to predict a malignant tumour (M features): Irregular solid tumour (M1), Ascites (M2), At least four papillary structures (M3), Irregular multilocular solid tumour with a largest diameter of at least 100 mm (M4) Very high colour content on colour Doppler examination (M5). ABOUBAKR ELNASHAR1/19/2019
  • 25.
    5 ultrasonic featuresto predict a benign tumour (B features): Unilocular cyst (B1), Presence of solid components for which the largest solid component is <7 mm in largest diameter (B2) Acoustic shadows (B3) Smooth multilocular tumour (B4) No detectable blood flow on Doppler examination (B5). ABOUBAKR ELNASHAR1/19/2019
  • 26.
  • 27.
  • 28.
    5 - 10cm  color Doppler and possibly MRI  Observation  simple cystic appearance (Schmeler, 2005; Zan etta, 2003) .  Excision  display malignant qualities  symptomatic  cysts grow 10 cm: Excision {substantial risk of malignancy, torsion, or labor obstruction} 1/19/2019 ABOUBAKR ELNASHAR
  • 29.
     Resection  When at 14 to 20 w  {most masses that will regress will have done so by this time}.  If the corpus luteum is removed before 10W: 17-OH-progesterone, 250 mg IM/W tell 10W gestation.  Laparoscopic removal is ideal (Naqvi, 20 1 5 ; Sisodia, 2015 )  If cancer is strongly suspected,  consultation with a gynecologic oncologist. (ACOG, 2017) 1/19/2019 ABOUBAKR ELNASHAR
  • 30.
    During CS: If diagnosedduring ante natal  Plan of management before delivery.  Consent for removal  Paracentesis for huge masses to minimize their volume and avoid complications  Endometrioma or mature cystic teratoma  may be resected  postpartum or  during CS for obstetrical indications. 1/19/2019 ABOUBAKR ELNASHAR
  • 31.
     Removal ofall masses during CS, especially if the larger than 5 cm,  Why? 1. to prevent  subsequent complications:  torsion or rupture  future requirement for surgery 2. removal during CS was not associated with any complications.  Why all masses considerable proportion of neoplastic lesions were smaller than 5 cm 1/19/2019 ABOUBAKR ELNASHAR
  • 32.
    If incidentally discovered Incidence: 1 in 200  Exteriorizing the uterus during CS:  less intraoperative complications  less hemorrhage  better inspection of pelvic organs: incidental adnexal mass discovery not such a rare event. 1/19/2019 ABOUBAKR ELNASHAR
  • 33.
     Medico-legal issueson the informed consenting process  additional procedures during CS should not be carried out without further discussion with the woman  This includes procedures which  may be appropriate but  not essential at the time,  such as ovarian cystectomy or oophorectomy  Additional non-emergency procedures during a cesarean section should not be carried out without the consent of the woman. [RCOG, 2016]. . 1/19/2019 ABOUBAKR ELNASHAR
  • 34.
    Under general anesthesia If an ovarian cyst suggestive of malignancy: • Seek an on-the-table review by an oncology specialist. • Take peritoneal washings for cytology. • Consider biopsies of cyst wall or visible peritoneal lesions.  when she is conscious  Inform the patient of the findings  seek her permission to send any specimens for laboratory investigations.  Plan definitive management in consultation with a gynecologic oncologist. 1/19/2019 ABOUBAKR ELNASHAR
  • 35.
    Under regional anesthesia •Inform and seek consent for further management. • If the cyst appears benign:  consider performing a cystectomy, but without spillage of cyst contents. • If the cyst suggestive of malignancy:  take peritoneal washings  consider performing an oophorectomy with or without additional surgery.  The procedure should be performed by an oncology specialist.  Once histology is available, interval staging laparotomy can be planned as appropriate. 1/19/2019 ABOUBAKR ELNASHAR
  • 36.
     Incidental adnexalmasses should be surgically removed,  avoiding later surgery  establishing malignancy status of the mass.  no complication or increase of morbidity and mortality  safe surgical act. 1/19/2019 ABOUBAKR ELNASHAR
  • 37.
     Type ofoperation  depending on the 1. manifestation of the masses. 2. exclude malignancies  with a biopsy (or wedge resection) and then freeze the section in order to avoid unnecessary surgical excision.  frozen section  offers a great help in making an intraoperative decision  unfortunately a 24 hs frozen section examination not available.  referral of the patient to an oncological center after CS will not influence negatively the patient’s chances.1/19/2019 ABOUBAKR ELNASHAR
  • 38.
     Cystectomy  isthe recommended procedure, if no malignancy  signs  Ovarectomy and ovarectomy with salpingectomy: complex cases.  ovarian masses should be removed intact when possible, especially in suspicious cases. 1/19/2019 ABOUBAKR ELNASHAR
  • 39.
    CONCLUSION  Preconception careand routine prenatal care, including USG examination, may optimize the detection and management of an adnexal mass.  Removal of incidental or known adnexal masses at cesarean section, especially if they are larger than 5cm. 1/19/2019 ABOUBAKR ELNASHAR
  • 40.
    You can getthis lecture and 400 lectures from: 1.My scientific page on Face book: Aboubakr Elnashar Lectures. https://www.facebook.com/groups/22774488 4091351/ 2.Slide share web site 3. elnashar53@hotmail.com 4.My clinic: Althwara st, Mansura, Egypt 1/19/2019 ABOUBAKR ELNASHAR